One of the major clinical problems in the treatment of people with schizophrenia is
suboptimal medication adherence. Most research focusing on determinants of …

Partial and non-adherence to medication is a common problem in schizophrenia, leading to
an increased risk of relapse, increased likelihood of hospitalization and poorer long-term …

Background Antipsychotic medications often have a variety of side effects, however, it is not
well understood how the presence of specific side effects correlate with adherence in a real …

Background: Lack of adherence to drug treatment is a major obstacle to disease control.
Although many studies have examined adherence to antipsychotic treatment, they have …

Background Nonadherence is a well-known problem among schizophrenia patients, among
whom relapse is fivefold more likely, adversely affecting health, employment, and social …

The purpose of this study was to examine patients' response profiles to the Medication
Adherence Rating Scale (MARS) and to evaluate the potential of response styles as …

Background Antipsychotic medication reduces the severity of serious mental illness (SMI)
and improves patient outcomes only when medicines were taken as prescribed …

Background Approximately half of service users with schizophrenia or bipolar disorder do
not fully follow treatment recommendations. Studies of adherence have not adequately …

Background Maintaining antipsychotic therapy in psychosis is important in preventing
relapse. Long-acting depot preparations can prevent covert non-adherence and thus …

BACKGROUND: Many patients recovering from a first psychotic episode will discontinue
medication against medical advice, even before a 1-year treatment course is completed …